The European Investment Bank and the European Commission were the early supporters of German BioNTech, the company which produced the first COVID-19 mRNA vaccine. BioNTech is now using its mRNA technology to develop a vaccine that could potentially eradicate malaria.
The EIB pledges to support them and other innovative companies in the fight against the disease. Working together for healthier lives!
